X-ray structures and analysis of 11 cyclosporin derivatives complexed with cyclophilin A

Journal of Molecular Biology

Volumn 283, Issue 2, 1998, Pages 435-449

  Kallen, Joerg ^a   Mikol, Vincent ^a   Taylor, Paul ^a   D walkinshaw, Malcolm ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cyclophilin; Cyclosporin A; Immunophilin; Ligand binding; Molecular recognition

Indexed keywords

CYCLOPHILIN A; CYCLOSPORIN DERIVATIVE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DATA BASE; DRUG PROTEIN BINDING; HYDROGEN BOND; LIGAND BINDING; MOLECULAR RECOGNITION; PRIORITY JOURNAL; STEREOCHEMISTRY; X RAY CRYSTALLOGRAPHY;

EID: 0032561136     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.2108     Document Type: Article

References (52)

1. Altschuh D., Braun W., Kallen J., Mikol V., Spitzfaden C., Thierry L.C., Vix O., Walkinshaw M.D., Wuthrich K. Conformational polymorphism of cyclosporine-a. Structure. 2:1994;963-972
2. Baker E.N., Hubbard R.E. Hydrogen-bonding in globular-proteins. Prog. Biophys. Mol. Biol. 44:1984;97-179
3. Bohm H.J. Ludi - rule-based automatic design of new substituents for enzyme-inhibitor leads. J. Comput. Aided Mol. Design. 6:1992;593-606
4. Bohm H.J. The development of a simple empirical scoring function to estimate the binding constant for a protein ligand complex of known 3-dimensional structure. J. Comput. Aided Mol. Design. 8:1994;243-256
5. Bohm H.J. Current computational tools for de-novo ligand design. Curr. Opin. Biotechnol. 7:1996;433-436
6. Bollinger P., Fliri H., Hiestand P., Payne T., Quesniaux V., Schreier M., Traber R., Tscherter H., Walkinshaw M., Weber H., Widmer H., Wenger R. Structure-activity studies on cyclosporine derivatives. Am. Chem. Soc. 200:1990;173. MEDI (Abstracts)
7. Braun W., Kallen J., Mikol V., Walkinshaw M.D., Wuthrich K. 3-Dimensional structure and actions of immunosuppressants and their immunophilins. FESEB J. 9:1995;63-72
8. Brünger A.T. X-PLOR Version 3.1: A System for X-ray Crystallography and NMR. 1993;Yale University Press, New Haven and London
9. Caflisch A., Karplus M. Computational combinatorial chemistry for de-novo ligand design - review and assessment. Perspect. Drug Discov. Design. 3:1995;51-84
10. Engh R.A., Huber R. Accurate bond and angle parameters for X-ray protein-structure refinement. Acta Crystallog. sect. A. 47:1991;392-400
11. Fliri H., Baumann G., Enz A., Kallen J., Luyten M., Mikol V., Movva R., Quesniaux V., Schreier M., Walkinshaw M., Wenger R., Zenke G., Zurini M. Cyclosporins - structure-activity-relationships. Ann. NY Acad. Sci. 696:1993;47-53
12. Galat A. Peptidylproline cis-trans-isomerases-immunophilins. Eur. J. Biochem. 216:1993;689-707
13. Galat A., Metcalfe S.M. Peptidylproline cis/trans isomerases. Prog. Biophys. Mol. Biol. 63:1995;67-118
14. Griffith J.P., Kim J.L., Kim E.E., Sintchak M.D., Thomson J.A., Fitzgibbon M.J., Fleming M.A., Caron P.R., Hsiao K., Navia M.A. X-ray structure of calcineurin inhibited by the immunophilin immunosuppressant fkbp12-fk506 complex. Cell. 82:1995;507-522
15. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J. Cyclophilin - a specific cytosolic binding-protein for cyclosporin-a. Science. 226:1984;544-547
16. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein models in electron-density maps and the location of errors in these models. Acta Crystallog. sect. A. 47:1991;110-119
17. Kallen J., Walkinshaw M.D. The x-ray structure of a tetrapeptide bound to the active-site of human cyclophilin-a. FEBS Letters. 300:1992;286-290
18. Ke H.M. Similarities and differences between human cyclophilin-a and other beta-barrel structures - structural refinement at 1.63 Å resolution. J. Mol. Biol. 228:1992;539-550
19. Kern G., Kern D., Schmid F.X., Fischer G. A kinetic-analysis of the folding of human carbonic-anhydrase-ii and its catalysis by cyclophilin. J. Biol. Chem. 270:1995;740-745
20. Kissinger C.R., Parge H.E., Knighton D.R., Lewis C.T., Pelletier L.A., Tempczyk A., Kalish V.J., Tucker K.D., Showalter R.E., Moomaw E.W., Gastinel L.N., Habuka N., Chen X.H., Maldonado F., Barker J.E., et al. Crystal-structures of human calcineurin and the human fkbp12-fk506-calcineurin complex. Nature. 378:1995;641-644
21. Ko S.Y., Dalvit C. Conformation of cyclosporine-a in polar-solvents. Int. J. Pept. Protein Res. 40:1992;380-382
22. Liu J., Albers M.W., Wandless T.J., Luan S., Alberg D.G., Belshaw P.J., Cohen P., Mackintosh C., Klee C.B., Schreiber S.L. Inhibition of t-cell signaling by immunophilin ligand complexes correlates with loss of calcineurin phosphatase-activity. Biochemistry. 31:1992;3896-3901
23. Loosli H.R., Kessler H., Oschkinat H., Weber H.P., Petcher T.J., Widmer A. Peptide conformations .31. The conformation of cyclosporin-a in the crystal and in solution. Helv Chim. Acta. 68:1985;682-704
24. Messerschmidt A., Pflugrath J.W. Crystal orientation and x-ray pattern prediction routines for area- detector diffractometer systems in macromolecular crystallography. J. Appl. Crystallog. 20:1987;306-315
25. Mikol V., Duc D. Crystallization of the complex between cyclophilin-a and cyclosporine derivatives - the use of cross-seeding. Acta Crystallog. sect. D. 50:1994;543-549
26. Mikol V., Kallen J., Pflugl G., Walkinshaw M.D. X-ray structure of a monomeric cyclophilin-a-cyclosporine-a crystal complex at 2.1 Å resolution. J. Mol. Biol. 234:1993;1119-1130
27. Mikol V., Kallen J., Walkinshaw M.D. The x-ray structure of (mebm(2)t)(1)-cyclosporine complexed with cyclophilin-a provides an explanation for its anomalously high immunosuppressive activity. Protein Eng. 7:1994;597-603
28. Mikol V., Papageorgiou C., Borer X. The role of water-molecules in the structure-based design of (5-hydroxynorvaline)-2-cyclosporine - synthesis, biological-activity, and crystallographic analysis with cyclophilin-a. J. Med. Chem. 38:1995;3361-3367
29. Morton A., Matthews B.W. Specificity of ligand-binding in a buried nonpolar cavity of t4 lysozyme - linkage of dynamics and structural plasticity. Biochemistry. 34:1995;8576-8588
30. Morton A., Baase W.A., Matthews B.W. Energetic origins of specificity of ligand-binding in an interior nonpolar cavity of t4 lysozyme. Biochemistry. 34:1995;8564-8575
31. Papageorgiou C., Borer X., French R.R. Calcineurin has a very tight-binding pocket for the side-chain of residue-4 of cyclosporine. Bioorg. Med. Chem. Letters. 4:1994;267-272
32. Papageorgiou C., Florineth A., Mikol V. Improved binding-affinity for cyclophilin-a by a cyclosporine derivative singly modified at its effector domain. J. Med. Chem. 37:1994;3674-3676
33. Papageorgiou C., Sanglier J.J., Traber R. Anti hiv-1 activity of a hydrophilic cyclosporine derivative with improved binding-affinity to cyclophilin-a. Bioorg. Med. Chem. Letters. 6:1996;23-26
34. Pflugl G., Kallen J., Schirmer T., Jansonius J.N., Zurini M.G.M., Walkinshaw M.D. X-ray structure of a decameric cyclophilin cyclosporine crystal complex. Nature. 361:1993;91-94
35. Pflugl G.M., Kallen J., Jansonius J.N., Walkinshaw M.D. The molecular replacement solution and x-ray refinement to 2. 8 Å of a decameric complex of human cyclophilin-a with the immunosuppressive drug cyclosporine-a. J. Mol. Biol. 244:1994;385-409
36. Quesniaux V.F.J., Schreier M.H., Wenger R.M., Hiestand P.C., Harding M.W., Vanregenmortel M.H.V. Molecular characteristics of cyclophilin-cyclosporine interaction. Transplantation. 46:1988;S23-S28
37. Rosenwirth B., Billich A., Datema R., Donatsch P., Hammerschmid F., Harrison R., Hiestand P., Jaksche H., Mayer P., Peichl P., Quesniaux V., Schatz F., Schuurman H.J., Traber R., Wenger R., et al. Inhibition of human-immunodeficiency-virus type-1 replication by sdz- nim-811, a nonimmunosuppressive cyclosporine analog. Antimicrob. Agents Chemother. 38:1994;1763-1772
38. Schonbrunner E.R., Mayer S., Tropschug M., Fischer G., Takahashi N., Schmid F.X. Catalysis of protein folding by cyclophilins from different species. J. Biol. Chem. 266:1991;3630-3635
39. Schreiber S.L., Albers M.W., Brown E.J. The cell-cycle, signal-transduction, and immunophilin ligand complexes. Acc. Chem. Res. 26:1993;412-420
40. Seebach D., Beck A.K., Bossler H.G., Gerber C., Ko S.Y., Murtiashaw C.W., Naef R., Shoda S., Thaler A., Krieger M., Wenger R. Modification of cyclosporine-a (cs) - generation of an enolate at the sarcosine residue and reactions with electrophiles. Helv. Chim. Acta. 76:1993;1564-1590
41. Sigal N.H., Dumont F., Durette P., Siekierka J.J., Peterson L., Rich D.H., Dunlap B.E., Staruch M.J., Melino M.R., Koprak S.L., Williams D., Witzel B., Pisano J.M. Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporine-a. J. Exp. Med. 173:1991;619-628
42. Spitzfaden C., Braun W., Wider G., Widmer H., Wuthrich K. Determination of the nmr solution structure of the cyclophilin-a-cyclosporine-a complex. J. Biomol. NMR. 4:1994;463-482
43. Taylor P., Husi H., Kontopidis G., Walkinshaw M.D. Structures of cyclophilin-ligand complexes. Prog. Biophys. Mol. Biol. 67:1997;155-181
44. Thanki N., Umrania Y., Thornton J.M., Goodfellow J.M. Analysis of protein main-chain solvation as a function of secondary structure. J. Mol. Biol. 221:1991;669-691
45. Theriault Y., Logan T.M., Meadows R., Yu L.P., Olejniczak E.T., Holzman T.F., Simmer R.L., Fesik S.W. Solution structure of the cyclosporine-a cyclophilin complex by NMR. Nature. 361:1993;88-91
46. Verkhivker G., Appelt K., Freer S.T., Villafranca J.E. Empirical free-energy calculations of ligand-protein crystallographic complexes. 1. Knowledge-based ligand-protein interaction potentials applied to the prediction of human-immunodeficiency-virus-1 protease binding-affinity. Protein Eng. 8:1995;677-691
47. Wenger R.M. Synthesis of cyclosporine and analogs - structural requirements for immunosuppressive activity. Angewandte Chemie-Internat. (edition in English). 24:1985;77-85
48. Wenger R.M. Structures of cyclosporine and its metabolites. Transplant. Proc. 22:1990;1104-1108
49. Wenger R.M., Martin K., Timbers C., Tromelin A. Structure of cyclosporine and its metabolites - total synthesis of cyclosporine metabolites formed by oxidation at position-4 and position-9 of cyclosporine - preparation of leucine-4-cyclosporine, (gamma-hydroxy)-N-methyl-leucine-9-cyclosporine and leucine-4-(gamma-hydroxy)-N-methyl-leucine-9-cyclosporine. Chimia. 46:1992;314-322
50. Wenger R.M., France J., Bovermann G., Walliser L., Widmer A., Widmer H. The 3D structure of a cyclosporine analog in water is nearly identical to the cyclophilin-bound cyclosporine conformation. FEBS Letters. 340:1994;255-259
51. Widmer A. WITNOTP: A Computer Program for Molecular Modelling. 1997;Sandoz AG, Basel
52. Williams M.A., Goodfellow J.M., Thornton J.M. Buried waters and internal cavities in monomeric proteins. Protein Sci. 3:1994;1224-1235